Skip to content

Krystal Biotech, Inc. KRYS Income Taxes Payable

Income Taxes Payable at other companies

Roivant Sciences logo
Roivant SciencesROIV
$45.69M+10,883%
Biogen logo
BiogenBIIB
$93.6M-85.1%
Viatris logo
ViatrisVTRS
$0-100%
Incyte logo
IncyteINCY
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN

Other financials

Income statement

See full
Revenue$116.4M+31.9%
Operating income$53.7M+48.1%
Net income$55.9M+56.5%
EPS (diluted)$1.83+52.5%

Balance sheet

See full
Cash & equivalents$501.3M+62.4%
Total debt$9.1M-5.7%
Total equity$1.3B+29.7%
Total assets$1.4B+30.0%

Cash flow

See full
Operating cash flow$80.4M+160%
CapEx$7.1M+15.2%
Free cash flow$73.2M+196%

Valuation

See full
Market cap$10.26B+45.4%
Enterprise value$9.77B+44.2%
P/E45.6×-11.3×
P/S24.6×+3.4×

Profitability

See full
Operating margin42.8%+10.2pp
Net margin53.9%+16.7pp
FCF margin56.9%+16.5pp

Returns & leverage

See full
Return on equity19.9%+6.0pp
Debt / equity0.0×
Current ratio9.5×-0.2×

Where this comes from

Reported directly by Krystal Biotech, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedIncomeTaxes.

The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Krystal Biotech, Inc.'s income taxes payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Krystal Biotech, Inc.'s income taxes payable?
Krystal Biotech, Inc. (KRYS) reported income taxes payable of $13.11M in Q1 2026.
How has Krystal Biotech, Inc.'s income taxes payable changed year-over-year?
Krystal Biotech, Inc.'s income taxes payable increased by 14.7% year-over-year, from $11.43M to $13.11M.
What is the long-term trend for Krystal Biotech, Inc.'s income taxes payable?
Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s income taxes payable has grown at a 207.1% compound annual growth rate (CAGR), from $40K to $10.92M.